XML 54 R28.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Schedule II - Condensed Financial Information | 12 Months Ended
--- | ---
Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract] |
Condensed Financial Information of Parent Company Only Disclosure | SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT
Condensed Balance Sheets
| December 31,
| 2021 |  | 2020
Assets |  |  |
Fixed maturities, available-for-sale, at fair value | $ | 2,727 |  |  | $ | 2,971 |
Equity securities, at fair value | 117 |  |  | 114 |
Cash and cash equivalents | 4,321 |  |  | 17,828 |
Accrued investment income | 9 |  |  | 9 |
Investment in subsidiaries | 532,432 |  |  | 562,448 |
Goodwill | 10,157 |  |  | 10,157 |
Property and equipment, net | 8,568 |  |  | 9,144 |
Other assets | 4,119 |  |  | 6,944 |
Total Assets | $ | 562,450 |  |  | $ | 609,615 |
Liabilities |  |  |
Intercompany payable | $ | 78,540 |  |  | $ | 37,401 |
Accounts payable and accrued expenses | 392 |  |  | 1,352 |
Lease liabilities | 32 |  |  | 46 |
Other liabilities | — |  |  | 1,679 |
Long-term notes payable | 151,267 |  |  | 151,276 |
Total Liabilities | 230,231 |  |  | 191,754 |
Stockholders’ Equity |  |  |
Common stock | 4 |  |  | 4 |
Additional paid-in capital | 394,268 |  |  | 393,122 |
Treasury stock | (431) |  |  | (431) |
Accumulated other comprehensive income | (6,531) |  |  | 9,693 |
Retained earnings | (74,642) |  |  | (6,373) |
Total UIHC Stockholders’ Equity | 312,668 |  |  | 396,015 |
Noncontrolling Interests | 19,551 |  |  | 21,846 |
Total Stockholders’ Equity | 332,219 |  |  | 417,861 |
Total Liabilities and Stockholders’ Equity | $ | 562,450 |  |  | $ | 609,615 |
SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT, CONTINUED
Condensed Statements of Comprehensive Loss
|  | Years Ended December 31,
|  | 2021 |  | 2020 |  | 2019
REVENUE: |  |  |  |  |  |
Net loss from subsidiaries (equity method) |  | $ | (52,492) |  |  | $ | (83,434) |  |  | $ | (24,131) |
Net realized investment gain |  | — |  |  | 4,971 |  |  | 63 |
Net investment income |  | 46 |  |  | 520 |  |  | 1,156 |
Net unrealized gain (loss) on equity securities |  | (1) |  |  | (2,812) |  |  | 4,036 |
Total revenues |  | (52,447) |  |  | (80,755) |  |  | (18,876) |
EXPENSES: |  |  |  |  |  |
Operating and underwriting |  | 380 |  |  | 181 |  |  | 219 |
General and administrative |  | 1,995 |  |  | 6,912 |  |  | 3,042 |
Interest expense |  | 9,302 |  |  | 9,465 |  |  | 9,499 |
Total expenses |  | 11,677 |  |  | 16,558 |  |  | 12,760 |
Loss before other income |  | (64,124) |  |  | (97,313) |  |  | (31,636) |
Other income |  | — |  |  | — |  |  | — |
Loss before income taxes |  | (64,124) |  |  | (97,313) |  |  | (31,636) |
Provision for income tax benefit |  | (4,256) |  |  | (1,815) |  |  | (2,151) |
Net loss |  | $ | (59,868) |  |  | $ | (95,498) |  |  | $ | (29,485) |
Less: Net income (loss) attributable to NCI |  | (1,949) |  |  | 956 |  |  | 387 |
Net loss attributable to UIHC |  | $ | (57,919) |  |  | $ | (96,454) |  |  | $ | (29,872) |
Unrealized gain (loss) on investments |  | (18,267) |  |  | 64,726 |  |  | 28,366 |
Reclassification adjustments - gains |  | (3,567) |  |  | (66,691) |  |  | (1,228) |
Income tax benefit (expense) related to other items of comprehensive income |  | 5,264 |  |  | 502 |  |  | (6,588) |
Total comprehensive loss |  | $ | (76,438) |  |  | $ | (96,961) |  |  | $ | (8,935) |
Less: Comprehensive income (loss) attributable to NCI |  | (2,295) |  |  | 1,119 |  |  | 588 |
Total comprehensive loss attributable to UIHC |  | $ | (74,143) |  |  | $ | (98,080) |  |  | $ | (9,523) |
SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT, CONTINUED
Condensed Statements of Cash Flows
| Year Ended December 31,
| 2021 |  | 2020 |  | 2019
OPERATING ACTIVITIES |  |  |  |  |
Net loss | $ | (59,868) |  |  | $ | (95,498) |  |  | $ | (29,485) |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |
Dividends received from subsidiaries (1) | 3,500 |  |  | 11,998 |  |  | 11,814 |
Losses from subsidiaries (1) | 52,492 |  |  | 83,434 |  |  | 24,131 |
Depreciation and amortization | 1,222 |  |  | 2,054 |  |  | 1,131 |
Bond amortization | 2 |  |  | 42 |  |  | 66 |
Unrealized losses (gains) on equities | 1 |  |  | 2,812 |  |  | (4,036) |
Net realized investment losses (gains) | — |  |  | (4,971) |  |  | (63) |
Deferred income taxes, net | 314 |  |  | 644 |  |  | (511) |
Stock based compensation | 1,185 |  |  | 1,382 |  |  | 3,007 |
Disposal of fixed assets | — |  |  | 2,763 |  |  | — |
Changes in operating assets and liabilities: |  |  |  |  |
Accrued investment income | — |  |  | 70 |  |  | 113 |
Other assets | 2,516 |  |  | (3,682) |  |  | 9,976 |
Accounts payable and accrued expenses | (960) |  |  | 931 |  |  | (22) |
Intercompany payable (1) | 6,139 |  |  | 3,232 |  |  | 4,503 |
Lease liabilities | (14) |  |  | (18) |  |  | 64 |
Other liabilities | (1,972) |  |  | 966 |  |  | 313 |
Net cash provided by operating activities | 4,557 |  |  | 6,159 |  |  | 21,001 |
INVESTING ACTIVITIES |  |  |  |  |
Proceeds from sales of investments available-for-sale | 1,112 |  |  | 32,518 |  |  | 35,036 |
Purchases of investments available-for-sale | (940) |  |  | (317) |  |  | (3,567) |
Investment in subsidiaries (1) | (42,500) |  |  | (15,000) |  |  | (17,000) |
Cost of property and equipment acquired | — |  |  | (688) |  |  | (4,749) |
Net cash provided by (used in) investing activities | (42,328) |  |  | 16,513 |  |  | 9,720 |
FINANCING ACTIVITIES |  |  |  |  |
Tax withholding payment related to net settlement of equity awards | (39) |  |  | (112) |  |  | (296) |
Intercompany borrowings from our non-insurance subsidiaries (1) | 37,000 |  |  | 10,768 |  |  | 12,300 |
Repayments of intercompany borrowings to our non-insurance subsidiaries (1) | (2,000) |  |  | (8,000) |  |  | (33,505) |
Repayments of borrowings | (347) |  |  | (347) |  |  | (347) |
Dividends | (10,350) |  |  | (10,313) |  |  | (10,280) |
Net cash provided by (used in) financing activities | 24,264 |  |  | (8,004) |  |  | (32,128) |
Increase (decrease) in cash | (13,507) |  |  | 14,668 |  |  | (1,407) |
Cash and cash equivalents at beginning of period | 17,828 |  |  | 3,160 |  |  | 4,567 |
Cash and cash equivalents at end of period | $ | 4,321 |  |  | $ | 17,828 |  |  | $ | 3,160 |
(1) Previously, dividends received and losses from subsidiaries were incorrectly reported net in “Investment in subsidiaries” in net cash provided by (used in) investing activities in 2020 and 2019. As a result, the Condensed Statements of Cash Flows has been revised to correctly present $11,998,000 and $11,814,000 as “Dividends received from subsidiaries” in 2020 and 2019, respectively, and $83,434,000 and $24,131,000 as “Losses from subsidiaries” in 2020 and 2019, respectively, in net cash provided by (used in) operating activities. Furthermore, the intercompany borrowings from (to) our non-insurance subsidiaries were incorrectly reported net in "Change in intercompany payable" in net cash provided by (used in) operating activities in 2020 and 2019. As a result, the Condensed Statements of Cash Flows has been revised to correctly present $10,768,000 and $12,300,000 as "Intercompany borrowings from our non-insurance subsidiaries" in 2020 and 2019, respectively, and $8,000,000 and $33,505,000 as "Repayments of intercompany borrowings to our non-insurance subsidiaries" in 2020 and 2019, respectively, in net cash provided by (used in) financing activities." Notes to Condensed Financial Statements - Basis of Presentation The Company’s investment in subsidiaries is stated at cost plus equity in the undistributed earnings of subsidiaries since the date of acquisition. The Company’s share of net income of its subsidiaries is included in income using the equity method. These financial statements should be read in conjunction with UPC Insurance’s consolidated financial statements contained in Part II, Item 8 of this Form 10-K.

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -Section S99 -Paragraph 6 -Subparagraph (SX 210.5-04(Schedule I)) -URI http://asc.fasb.org/extlink&oid=120391182&loc=d3e5864-122674 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=123454820&loc=d3e5283-111683 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration